Article Text

Download PDFPDF
Original article
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
  1. Annieke C G van Baar1,
  2. Frits Holleman2,
  3. Laurent Crenier3,
  4. Rehan Haidry4,
  5. Cormac Magee5,
  6. David Hopkins6,
  7. Leonardo Rodriguez Grunert7,
  8. Manoel Galvao Neto8,9,
  9. Paulina Vignolo7,
  10. Bu’Hussain Hayee10,
  11. Ann Mertens11,
  12. Raf Bisschops12,
  13. Jan Tijssen13,
  14. Max Nieuwdorp14,
  15. Caterina Guidone15,
  16. Guido Costamagna16,
  17. Jacques Devière17,
  18. Jacques J G H M Bergman1
  1. 1Gastroenterology and Hepatology, Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands
  2. 2Internal Medicine, Amsterdam University Medical Centers, location Academic Medical Center, Amsterdam, The Netherlands
  3. 3Endocrinology, Erasme University Hospital, Brussels, Belgium
  4. 4Gastroenterology, University College Hospital, London, UK
  5. 5Centre for Obesity Research, Department of Medicine, University College Hospital, London, UK
  6. 6Institute of Diabetes, Endocrinology and Obesity, King’s Health Partners, London, UK
  7. 7CCO Clinical Center for Diabetes, Obesity and Reflux, Santiago, Chile
  8. 8Bariatric Endoscopy Service, Gastro Obeso Center, Sao Paulo, Brazil
  9. 9College of Medicine, Florida International University, Miami, Florida, USA
  10. 10Gastroenterology, King’s College Hospital, London, UK
  11. 11Clinical and Experimental Endocrinology, Catholic University of Leuven, Leuven, Belgium
  12. 12Gastroenterology and Hepatology, Catholic University of Leuven, Leuven, Belgium
  13. 13Cardiology, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands
  14. 14Internal and Vascular Medicine, Amsterdam University Medical Centers, location AMC, Amsterdam, The Netherlands
  15. 15Internal Medicine, Fondazione Policlinico A. Gemelli IRCSS, Rome, Italy
  16. 16Digestive Endoscopy Unit, Catholic University, Gemelli University Hospital, Roma, Italy
  17. 17Gastroenterology, Erasme University Hospital, Brussels, Belgium
  1. Correspondence to Prof. Jacques J G H M Bergman, Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location Academic Medical Center, Amsterdam 1105, The Netherlands; j.j.bergman{at}amc.nl

Footnotes

  • Contributors AvB participated in the design of the study and data analysis, saw patients at the site for screening and follow-ups, and wrote, edited, reviewed and approved the manuscript. FH participated in the design of the study and data analysis, saw patients at the site for screening and follow-ups, provided critical review of the manuscript and edited and approved the manuscript. AM, DH, LC, PV and CG saw patients at the site for screening and follow-ups, and reviewed, edited and approved the manuscript. RH, LRG, MGN, BH, RB, GC and JD performed the study procedures, and reviewed, edited and approved the manuscript. CM and DZ saw patients at the site for screening and follow-ups, provided critical review of the manuscript and edited and approved the manuscript. JT participated in the design of the study and data analysis, provided critical review of the manuscript and edited and approved the manuscript. MN participated in the design of the study, provided critical review of the manuscript and edited and approved the manuscript. JJGHMB participated in the design of the study, performed the study procedures, provided critical review of the manuscript, edited and approved the manuscript. JJGHMB is the guarantor of this work and, as such, had full access to all the data in the study, takes responsibility for the integrity of the data and the accuracy of the data analysis and had final responsibility for the decision to submit for publication.

  • Funding This study was funded by Fractyl Laboratories.

  • Competing interests FH reports speaker fees from Sanofi, Bioton and Astra Zeneca. DH reports consultancy for Novo Nordisk, Sanofi and Roche and speaker fees from Novo Nordisk, Sanofi, Roche, Astra Zeneca, Boerhinger, Napp, Medtronic, Sunovion and Fractyl Laboratories. LRG reports consultancy for Fractyl Laboratories. MGN reports consultancy for Fractyl Laboratories, GI Dynamics, GI Windows, Ethicon EndoSurgery, Meditronics, Apollo EndoSurgery, Consultant and Scientific Advisory Board member for GI Dynamics and Faculty in training courses for Ethicon EndoSurgery and Meditronics.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors AvB participated in the design of the study and data analysis, saw patients at the site for screening and follow-ups, and wrote, edited, reviewed and approved the manuscript. FH participated in the design of the study and data analysis, saw patients at the site for screening and follow-ups, provided critical review of the manuscript and edited and approved the manuscript. AM, DH, LC, PV and CG saw patients at the site for screening and follow-ups, and reviewed, edited and approved the manuscript. RH, LRG, MGN, BH, RB, GC and JD performed the study procedures, and reviewed, edited and approved the manuscript. CM and DZ saw patients at the site for screening and follow-ups, provided critical review of the manuscript and edited and approved the manuscript. JT participated in the design of the study and data analysis, provided critical review of the manuscript and edited and approved the manuscript. MN participated in the design of the study, provided critical review of the manuscript and edited and approved the manuscript. JJGHMB participated in the design of the study, performed the study procedures, provided critical review of the manuscript, edited and approved the manuscript. JJGHMB is the guarantor of this work and, as such, had full access to all the data in the study, takes responsibility for the integrity of the data and the accuracy of the data analysis and had final responsibility for the decision to submit for publication.

  • Funding This study was funded by Fractyl Laboratories.

  • Competing interests FH reports speaker fees from Sanofi, Bioton and Astra Zeneca. DH reports consultancy for Novo Nordisk, Sanofi and Roche and speaker fees from Novo Nordisk, Sanofi, Roche, Astra Zeneca, Boerhinger, Napp, Medtronic, Sunovion and Fractyl Laboratories. LRG reports consultancy for Fractyl Laboratories. MGN reports consultancy for Fractyl Laboratories, GI Dynamics, GI Windows, Ethicon EndoSurgery, Meditronics, Apollo EndoSurgery, Consultant and Scientific Advisory Board member for GI Dynamics and Faculty in training courses for Ethicon EndoSurgery and Meditronics.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.